Vanguard Group Inc. boosted its position in Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 4.0% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 10,271,428 shares of the company's stock after acquiring an additional 390,924 shares during the period. Vanguard Group Inc. owned 3.92% of Ryan Specialty worth $758,750,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in RYAN. Whittier Trust Co. of Nevada Inc. grew its holdings in Ryan Specialty by 281.6% during the 1st quarter. Whittier Trust Co. of Nevada Inc. now owns 332 shares of the company's stock valued at $25,000 after buying an additional 245 shares in the last quarter. Golden State Wealth Management LLC purchased a new stake in Ryan Specialty in the first quarter worth approximately $35,000. Kapitalo Investimentos Ltda bought a new stake in Ryan Specialty in the fourth quarter valued at approximately $36,000. Fifth Third Bancorp lifted its position in Ryan Specialty by 202.5% in the first quarter. Fifth Third Bancorp now owns 484 shares of the company's stock valued at $36,000 after purchasing an additional 324 shares during the last quarter. Finally, GAMMA Investing LLC lifted its position in Ryan Specialty by 21.8% in the first quarter. GAMMA Investing LLC now owns 2,101 shares of the company's stock valued at $155,000 after purchasing an additional 376 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors.
Ryan Specialty Stock Down 0.6%
Shares of NYSE RYAN traded down $0.37 during trading on Friday, reaching $59.14. The company had a trading volume of 731,805 shares, compared to its average volume of 1,523,210. Ryan Specialty Holdings Inc. has a 12-month low of $55.77 and a 12-month high of $77.16. The stock has a market cap of $15.60 billion, a PE ratio of 168.98, a P/E/G ratio of 1.64 and a beta of 0.64. The business's 50-day moving average is $64.25 and its 200 day moving average is $67.74. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.88.
Ryan Specialty (NYSE:RYAN - Get Free Report) last released its earnings results on Thursday, July 31st. The company reported $0.66 EPS for the quarter, hitting analysts' consensus estimates of $0.66. Ryan Specialty had a return on equity of 48.70% and a net margin of 6.81%. The firm had revenue of $855.17 million for the quarter, compared to analysts' expectations of $837.52 million. During the same period in the prior year, the firm posted $0.58 earnings per share. The company's quarterly revenue was up 23.0% on a year-over-year basis. As a group, equities analysts forecast that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current fiscal year.
Ryan Specialty Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 26th. Investors of record on Tuesday, August 12th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Tuesday, August 12th. This represents a $0.48 annualized dividend and a dividend yield of 0.8%. Ryan Specialty's dividend payout ratio (DPR) is 137.14%.
Insider Buying and Selling at Ryan Specialty
In related news, Director David P. Bolger sold 5,000 shares of the stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total transaction of $354,000.00. Following the sale, the director directly owned 71,467 shares of the company's stock, valued at $5,059,863.60. This trade represents a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Mark Stephen Katz sold 14,377 shares of the stock in a transaction on Friday, June 13th. The shares were sold at an average price of $65.84, for a total value of $946,581.68. Following the sale, the executive vice president directly owned 1,117 shares in the company, valued at $73,543.28. This trade represents a 92.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 52.21% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on RYAN shares. The Goldman Sachs Group upgraded Ryan Specialty from a "neutral" rating to a "buy" rating and upped their target price for the company from $74.00 to $81.00 in a report on Tuesday, May 13th. Barclays reduced their price target on Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating on the stock in a research note on Monday, July 7th. Morgan Stanley reduced their price target on Ryan Specialty from $78.00 to $71.00 and set an "overweight" rating on the stock in a research note on Friday, August 8th. UBS Group reduced their price target on Ryan Specialty from $84.00 to $80.00 and set a "buy" rating on the stock in a research note on Monday, August 4th. Finally, Citigroup assumed coverage on Ryan Specialty in a research note on Wednesday. They issued a "buy" rating and a $74.00 price target on the stock. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $75.08.
View Our Latest Stock Report on RYAN
About Ryan Specialty
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Recommended Stories

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.